Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NRL972 Pharmacokinetics in Chronic Viral Hepatitis B or C
NCT00915057Phase 2Completed
- Sponsor
- Norgine
- Start
- Mar 2009
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of fluorescein lisicol in Chronic Hepatitis B (CHB), hepatitis C (HCV), sponsored by Norgine. Started Mar 2009; status: completed.
02
Drugs
fluorescein lisicol
03
Conditions
Chronic Hepatitis B (CHB)hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00915057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915057.